Anixa Biosciences (ANIX)
2.76
0.00 (0.00%)
Upcoming Events
Latest Headlines
Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
September 11, 2026 9:01 AM - StreetInsider
Form 4 Anixa Biosciences Inc For: Sep 10 Filed by: KUMAR AMIT
September 11, 2026 8:00 AM - SEC Filing
Anixa Biosciences to Present at the 2026 Cantor Fitzgerald Global Healthcare Conference Highlighting its Breast Cancer Vaccine and Ovarian Cancer CAR-T Therapy
August 24, 2026 8:55 AM - PR NewsWire
Anixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
August 18, 2026 8:45 AM - PR NewsWire
Form 4 Anixa Biosciences Inc For: Jul 31 Filed by: KUMAR AMIT
August 3, 2026 8:46 AM - SEC Filing
Form 4 Anixa Biosciences Inc For: Jul 27 Filed by: Baskies Arnold M
July 29, 2026 9:15 AM - SEC Filing
Form 4 Anixa Biosciences Inc For: Jul 27 Filed by: KUMAR AMIT
July 28, 2026 10:20 AM - SEC Filing
Form 4 Anixa Biosciences Inc For: Jul 27 Filed by: KUMAR AMIT
July 27, 2026 3:25 PM - SEC Filing
Form 4 Anixa Biosciences Inc For: Jul 24 Filed by: KUMAR AMIT
July 27, 2026 9:01 AM - SEC Filing
Form 4 Anixa Biosciences Inc For: Jul 20 Filed by: KUMAR AMIT
July 21, 2026 10:23 AM - SEC Filing
Form 4 Anixa Biosciences Inc For: Jul 20 Filed by: Titterton Lewis H jr
July 20, 2026 6:19 PM - SEC Filing
Form 4 Anixa Biosciences Inc For: Jul 15 Filed by: Titterton Lewis H jr
July 16, 2026 9:00 AM - SEC Filing
Form 4 Anixa Biosciences Inc For: Jul 10 Filed by: KUMAR AMIT
July 13, 2026 9:00 AM - SEC Filing
Anixa ovarian cancer CAR-T trial advances to fifth dose cohort
July 6, 2026 8:32 AM - StreetInsider
Anixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose Level to Date
July 6, 2026 8:30 AM - PR NewsWire
Anixa Biosciences receives South Korean patent for breast cancer vaccine
June 29, 2026 8:45 AM - StreetInsider
Anixa Biosciences Granted First Korean Patent for its Breast Cancer Vaccine, Extending Global Protection Through 2040
June 29, 2026 8:45 AM - PR NewsWire
Anixa shares Phase 1 data on breast cancer vaccine and CAR-T therapy
June 26, 2026 9:10 AM - StreetInsider
Anixa Biosciences Reports Positive Data from Completed Breast Cancer Vaccine Phase 1 Trial and Positive Survival Observations from Ongoing CAR-T Phase 1 Trial at New York Academy of Sciences' Frontier
June 26, 2026 9:10 AM - PR NewsWire
Form 4 Anixa Biosciences Inc For: Jun 16 Filed by: Titterton Lewis H jr
June 17, 2026 11:21 AM - SEC Filing
Form 4 Anixa Biosciences Inc For: Jun 12 Filed by: KUMAR AMIT
June 16, 2026 9:00 AM - SEC Filing
Full Article List
